Testing: Tissue Testing

When a biopsy is taken from a tumor, the tissue must be analyzed for cell abnormalities to determine if it is cancerous and malignant. Analysis also reveals the type of cancer the patient has.

The first type of test uses a process called flow cytometry. Flow cytometry is done in a high-tech machine. The process sorts through the cells from the biopsy and examines them for certain cell markers that are found in the membranes of cells. These markers, called clusters of differentiation (CD), identify certain types of cancer cells.

The second test examines the DNA of biopsied cells. Laboratory technicians examine DNA for genetic abnormalities. These abnormalities cause the mutations in cancerous cells, which causes them to grow faster than normal, healthy cells, thus creating a tumor. Identification of these abnormalities helps classify cancer.

Once the biopsied tissue is examined using both of these techniques, the doctor can identify the type of cancer a patient has and then perform the necessary tests to stage the disease.

These tests are also useful in determining the type of treatment to give a patient. Some cell markers bind with antibodies – "tags" that mark the cell for removal by the immune system – so immunotherapy can be used. For more information on this type of treatment, please see the article titled Monoclonal Antibody Therapy.

Dive Deeper

For more information on Hodgkin's disease, please see the following pages

For more information on Non-Hodgkin lymphoma, please see the following pages:

More Articles

More Articles

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

Is there such a thing as an average cost of chemotherapy? No. Not even close. In order for there to be an average cost of chemotherapy, one would...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

This entry looks at one of those types of lymphoma sometimes referred to simply as abdominal lymphoma. 'Lymphoma' is an umbrella term that...

Usually, even if a subtype of lymphoma is known to be indolent (slow-growing), it is considered a malignant...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma diagnosis is not difficult to determine once a patient and doctor begin to look for signs of cancer...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Hodgkin's Lymphoma a.k.a. Hodgkin's Disease is a malignant (cancerous) growth of cells in the lymphatic system...

Lymphoma is a general term for cancer in the lymph system. The lymph system is made up of many cells and organs, including the lymph nodes, thymus...